Main article: Stem cell laws
Stem cell laws and policy in the United States have had a complicated legal and political history.
Stem cells are cells found in all multi-cellular organisms. They were isolated in mice in 1981, and in humans in 1998.[1] In humans there are many types of stem cells, each with varying levels of potency. Potency is a measure of a cell's differentiation potential, or the number of other cell types that can be made from that stem cell. Embryonic stem cells are pluripotent stem cells derived from the inner cell mass of the blastocyst. These stem cells can differentiate into all other cells in the human body and are the subject of much scientific research. However, since they must be derived from early human embryos their production and use in research has been a hotly debated topic as the embryo most likely is destroyed in the process.
Stem cell treatments are a type of cell therapy that introduce new cells into adult bodies for possible treatment of cancer, diabetes, neurological disorders and other medical conditions. Stem cells have been used to repair tissue damaged by disease or age.[2]Cloning also might be done with stem cells. Pluripotent stem cells can also be derived from Somatic cell nuclear transfer which is a laboratory technique where a clone embryo is created from a donor nucleus. Somatic cell nuclear transfer is also tightly regulated amongst various countries.
Until recently, the principal source of human embryonic stem cells has been donated embryos from fertility clinics. In January 2007, researchers at Wake Forest University reported that "stem cells drawn from amniotic fluid donated by pregnant women hold much of the same promise as embryonic stem cells."[1]
In 2000, the NIH, under the administration of President Bill Clinton, issued "guidelines that allow federal funding of embryonic stem-cell research."[1]
In 1973, Roe v. Wade legalized abortion in the United States. Five years later, the first successful human in vitro fertilization resulted in the birth of Louise Brown in England. These developments prompted the federal government to create regulations barring the use of federal funds for research that experimented on human embryos.[3] In 1995, the NIH Human Embryo Research Panel advised the administration of President Bill Clinton to permit federal funding for research on embryos left over from in vitro fertility treatments and also recommended federal funding of research on embryos specifically created for experimentation. In response to the panel's recommendations, the Clinton administration, citing moral and ethical concerns, declined to fund research on embryos created solely for research purposes,[4] but did agree to fund research on left-over embryos created by in vitro fertility treatments. At this point, the Congress intervened and passed the Dickey-Wicker Amendment in 1995 (the final bill, which included the Dickey Amendment, was signed into law by Bill Clinton) which prohibited any federal funding for the Department of Health and Human Services be used for research that resulted in the destruction of an embryo regardless of the source of that embryo. In 1998, privately funded research led to the breakthrough discovery of human Embryonic stem cells (hESC). Stem cells are cells that have not differentiated yet.
No federal law ever did ban stem cell research in the United States, but only placed restrictions on funding and use, under Congress's power to spend.[5]
In February 2001, George W. Bush requested a review of the NIH's guidelines, and after a policy discussion within his circle of supporters, implemented a policy in August of that year to limit the number of embryonic stem cell lines that could be used for research.[1] (While he claimed that 78 lines would qualify for federal funding, only 19 lines were actually available.[1])
In April 2004, 206 members of Congress, including many moderate Republicans, signed a letter urging President Bush to expand federal funding of embryonic stem cell research beyond what Bush had already supported.
Excerpt from:
Stem cell laws and policy in the United States - Wikipedia ...
- The Science Of Health: Are Spinal Cord Injuries Irreversible? Know Science Advances That Can Cure Them In The Future - ABP Live - October 16th, 2023
- Biden Weaponized Health Care on Abortion, Transgender, COVID-19 - Daily Signal - April 23rd, 2023
- Can This Company's Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval? - Marketscreener.com - November 17th, 2022
- BIOADAPTIVES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Marketscreener.com - November 17th, 2022
- With fewer inmates (and officers), Michigan closes another prison - Bridge Michigan - September 12th, 2022
- Testol 140 Review, Real Testol-140 Reviews Before and After Results - Dailyuw - September 12th, 2022
- Can California deliver on its zero-emission car goal? - Los Angeles Times - September 12th, 2022
- Researchers revive abandoned technique in effort to make artificial human eggs in a test tube - STAT - August 3rd, 2022
- 'Incredibly prejudicial': Why Sacramento courts have caged cells, and why that'll change - Walla Walla Union-Bulletin - August 3rd, 2022
- Ethical Issues in Stem Cell Research - PubMed Central (PMC) - December 22nd, 2021
- Dream Body Clinic Stem Cell Therapy Stem Cells HGH - December 22nd, 2021
- Stem cells | healthdirect - December 22nd, 2021
- Human Embryonic Stem Cells | The Embryo Project Encyclopedia - December 22nd, 2021
- Stem cells, through a religious lens Harvard Gazette - December 22nd, 2021
- Scientists identify 2nd HIV patient whose body rid itself of virus - National Herald - November 21st, 2021
- Need to streamline research on CRISPR gene-editing technology: Experts - Business Standard - November 21st, 2021
- Atrial Fibrillation Market Growth Driven by Technological Advancements in AFib Systems and Solutions and Rapidly Increasing Geriatric Population -... - November 21st, 2021
- Could Regenerative Biology Work in Humans? - Harvard Magazine - July 21st, 2021
- Alberta and NWT Bishops OK vaccination for COVID Grandin Media - Grandin Media - December 3rd, 2020
- The way prisoners flag guard abuse, inadequate health care and unsanitary conditions Is broken - injusticewatch.org - December 3rd, 2020
- From Roaches To Medical Emergencies, Illinois Inmates Say Theres Nobody That We Can Really Go To For Help - WBEZ - December 3rd, 2020
- Alexion Receives Marketing Authorization from European Commission for New Formulation of ULTOMIRIS (ravulizumab) with Significantly Reduced Infusion... - November 20th, 2020
- California's Stem Cell Agency Will Get A Funding Boost From Prop 14. Here's A Look At Its History. - Capital Public Radio News - November 19th, 2020
- Stem Cell Banking Market is Projected to Reach $6,956 million by 2023 | Leading key players are Cord Blood Registry, ViaCord, Cryo-Cell, China Cord... - November 19th, 2020
- Locked up during the Waupun COVID surge - Wisconsin Examiner - November 19th, 2020
- Panelists debate the implications and ethics of stem cell research - Johns Hopkins News-Letter - November 2nd, 2020
- Rapid Reshore & Development and BrainStorm Cell Therapeutics Announce Agreement to Advance Construction of BrainStorm's US Manufacturing Facility... - November 2nd, 2020
- Is the Pro-Life Movement on a Collision Course with the Coronavirus? - The Dispatch - November 2nd, 2020
- Will Trevor Lawrence stay at Clemson to avoid the Jets? - Yahoo! Voices - November 2nd, 2020
- Spurs' Becky Hammon honored with impressive San Antonio mural - Yahoo! Voices - November 2nd, 2020
- Total Student Enrollment of China New Higher Education Group Achieves Strong Organic Growth to a New Record High -- Total Number of Enrolled Students... - November 2nd, 2020
- Elis announces the acquisition of 3 laundries in Brazil - Yahoo Finance UK - November 2nd, 2020
- Stem Cell Banking Market is forecast to reach $6,956 million by 2023 | ViaCord,Cryo-Cell, China Cord Blood Corporation, Cryo-Save - The Daily... - October 2nd, 2020
- Those linked to stem cell board received more than $2.1 billion - Capitol Weekly - September 16th, 2020
- Patenting Stem Cell Inventions in India- What to Expect? - Lexology - September 13th, 2020
- Global Stem Cell Banking Market Is Projected To Witness Vigorous Expansion By 2026 - Kewaskum Statesman News Journal - September 13th, 2020
- How Close Are We To Making Babies from Bone Marrow? - Discover Magazine - August 12th, 2020
- India could bleed itself dry amidst covid-19 crisis owing to blood shortage - ETHealthworld.com - July 12th, 2020
- Court rules controversial stem cell research is legal - July 10th, 2020
- Legal Issues in Stem Cell Therapy in the U.S. - Inventus Law - June 19th, 2020
- Restoring vision to the blind - Science Magazine - May 22nd, 2020
- Death of a Survivor - The New Republic - May 4th, 2020
- Could Cannabis Be an Effective Treatment for COVID-19? - Lab Manager Magazine - April 29th, 2020
- The Republicans who were once so pro-life they fought over one woman on life support now want to sacrifice grandma for the economy - The Independent - April 29th, 2020
- Russia's Humanitarian Law Obligations to Civilians in Occupied Ukrainian Territories in the Time of COVID-19 - Just Security - April 29th, 2020
- Merck Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity - PR Newswire UK - April 22nd, 2020
- Insights Into the $8.8 Billion Cell Therapy Industry, 2020-2027 - Rising Adoption of Regenerative Medicine, Introduction of Novel Platforms &... - March 17th, 2020
- The tragic life of Meredith Vieira - Nicki Swift - March 17th, 2020
- The 411 on Stem Cells: What They Are and Why It's Important to Be Educated - Legal Examiner - February 20th, 2020
- The Challenge of Bioethics to Decision-Making in the UK - Westminster Abbey - February 20th, 2020
- Penn announces seven 2020 Thouron Award winners - Penn: Office of University Communications - February 20th, 2020
- BrainStorm Cell Therapeutics to Present at the 2020 Biotech Showcase and 3rd Annual Neuroscience Innovation Forum at JPM Week - GlobeNewswire - January 7th, 2020
- Drugs, Biologics, and Regenerative Medicine in 2019: A Successful Year Ends with Promise of a More Challenging 2020 - JD Supra - December 21st, 2019
- Edited Transcript of MRKR.OQ earnings conference call or presentation 12-Nov-19 10:00pm GMT - Yahoo Finance - November 29th, 2019
- BrainStorm Announces Financial Results for the Third Quarter of 2019 and Provides a Corporate Update - GlobeNewswire - November 19th, 2019
- What to Know in Washington: Trump Ally in Impeachment Spotlight - Bloomberg Government - November 19th, 2019
- Do transhumanists need their own bill of rights? - Quartz - October 27th, 2019
- Does Stem Cell Therapy Work For Back Pain? - Regenexx - October 8th, 2019
- The Ethical, Social & Legal Issues of Cloning Animals ... - October 8th, 2019
- An Overview of Stem Cell Research | The Center for ... - October 5th, 2019
- Ethical Issues in Stem Cell Research | Endocrine Reviews ... - October 2nd, 2019
- Embryo - Wikipedia - October 2nd, 2019
- Legal Issues in Stem Cell Therapy in the U.S. - Royse Law Firm - September 14th, 2019
- Research With Stem Cells | American Medical Association - May 23rd, 2019
- Practical Problems with Embryonic Stem Cells - usccb.org - March 17th, 2019
- Stem Cells For Dummies: The Controvery, Pros and Cons ... - March 6th, 2019
- Human cloning - Wikipedia - February 18th, 2019
- stem cell | Definition, Types, Uses, Research, & Facts ... - December 12th, 2018
- Timeline of major events in stem cell research policy ... - August 25th, 2018
- stem-cells | ETHICAL, LEGAL, AND SOCIAL ISSUES - July 29th, 2018
- The Legal and Ethical Issues of Cloning That Make it ... - October 11th, 2017
- 5 Ethical and Legal Issues | Cord Blood: Establishing a ... - September 21st, 2017
- FDA Grants Orphan Drug Status to Cellect's ApoGraft for Acute GvHD and Chronic GvHD - PR Newswire (press release) - September 5th, 2017
- Of cell phones and swords things Amarilloans should know about new state laws - Amarillo.com - September 1st, 2017
- Cellect Shares Will Be Traded From Next Week Exclusively on NASDAQ - PR Newswire (press release) - September 1st, 2017
- ICMR to release stem cell research guidelines soon - BSI bureau (press release) - September 1st, 2017
- ICMR's stem cell research guidelines soon to be released - ETHealthworld.com - August 31st, 2017
- Should your medical data be off the record? - The Irish Times - Irish Times - August 25th, 2017
- Combatting the spread of anti-vaccination sentiment - OUPblog (blog) - August 25th, 2017
- Embryonic stem cell - Wikipedia - August 24th, 2017